Trials / Available
AvailableNCT07457593
Expanded Access for Inhaled Isoflurane Delivered Via the Sedaconda ACD-S for Sedation of Difficult-to-Sedate Adult Mechanically Ventilated Intensive Care Unit Patients
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Sedana Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this Expanded Access Protocol is to provide access to inhaled isoflurane delivered via the Sedaconda ACD-S device for sedation of adult patients in the ICU that are mechanically ventilated and are difficult to sedate with current available treatment options, and who, in the opinion of their treating physician, would benefit from this treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Isoflurane | Isoflurane for inhaled sedation |
| DEVICE | Sedaconda ACD-S | Sedaconda ACD-S is a medical device which enables the administration of volatile anesthetics (isoflurane) |
Timeline
- First posted
- 2026-03-09
- Last updated
- 2026-03-09
Source: ClinicalTrials.gov record NCT07457593. Inclusion in this directory is not an endorsement.